Literature DB >> 3320205

Removal of Langerhans cells from human epidermal cell suspensions by immunomagnetic particles.

H Nilsson1, C Johansson, A Scheynius.   

Abstract

The possibility of eliminating the class II antigen-expressing and antigen-presenting Langerhans cells from normal human epidermal cell suspensions was investigated. Cell suspensions containing 1.7-2.8% Langerhans cells were prepared by enzyme treatment of human skin obtained at plastic surgery. The cells were incubated with mouse monoclonal antibodies directed against the CD1 antigen present on Langerhans cells and were further incubated with magnetic particles, 4.5 micron in diameter, coated with sheep anti-mouse IgG. The optimal ratio between particles and target cells was found to be 40:1. The rosetted Langerhans cells were removed by a cobalt-samarium magnet. In six experiments immunoperoxidase staining revealed 0-0.1% (mean 0.03%) CD1-reactive Langerhans cells in the depleted cell fraction. The alloantigen presenting capacity of the depleted cell fraction, measured by [3H]thymidine incorporation, was abolished.

Entities:  

Mesh:

Year:  1987        PMID: 3320205     DOI: 10.1016/0022-1759(87)90262-6

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  3 in total

1.  Adhesion molecules and IL-1 costimulate T lymphocytes in the autologous MECLR in psoriasis.

Authors:  E Prens; K t Hooft-Benne; B Tank; J Van Damme; T van Joost; R Benner
Journal:  Arch Dermatol Res       Date:  1996-02       Impact factor: 3.017

2.  Purified human oral mucosal Langerhans cells function as accessory cells in vitro.

Authors:  A W Barrett; D A Ross; J A Goodacre
Journal:  Clin Exp Immunol       Date:  1993-04       Impact factor: 4.330

3.  Immunomagnetic separation as a final purification step of liver endothelial cells.

Authors:  D E Gomez; J L Hartzler; R H Corbitt; A M Nason; U P Thorgeirsson
Journal:  In Vitro Cell Dev Biol Anim       Date:  1993-06       Impact factor: 2.416

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.